quinoxalines has been researched along with Ischemia in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, PC; Ichhpujani, P; Narang, S; Sood, S | 1 |
| Gladwin, M; Isenberg, JS; Shiva, S | 1 |
| Leng, W; Qiu, W; Wang, W; Wei, R; Zhang, C | 1 |
| Chen, S; Mohajerani, MH; Murphy, TH; Xie, Y | 1 |
| Chai, S; Ellisman, MH; Ju, WK; Kim, KY; Lee, D; Lindsey, JD; Noh, YH; Weinreb, RN | 1 |
| Gyo, K; Hakuba, N; Hyodo, J; Maetani, T; Matsubara, A; Shimizu, Y; Shudou, M; Taniguchi, M; Tsujiuchi, Y | 1 |
| Chao, J; Hsieh, CM; Kawasaki, K; Liao, JK; Smith, RS; Sun, J | 1 |
| Choi, AM; Kaizu, T; Kimizuka, K; Murase, N; Nakao, A; Nalesnik, MA; Neto, JS; Otterbein, LE; Stolz, DB; Uchiyama, T; Zuckerbraun, BS | 1 |
| Avilés-Trigueros, M; García-Avilés, A; Lafuente, MP; Mayor-Torroglosa, S; Miralles de Imperial, J; Rodríguez, ME; Vidal-Sanz, M; Villegas-Pérez, MP | 1 |
| Baidya, KP; Bhaduri, G; Bhattacharya, B; Chatterjee, PR; Mondal, LK | 1 |
| Cronberg, T; Jensen, K; Rytter, A; Wieloch, T | 1 |
| Avilés-Trigueros, M; de Imperial, JM; De la Villa, P; García-Avilés, A; López-Herrera, MP; Mayor-Torroglosa, S; Rodríguez, ME; Vidal-Sanz, M; Villegas-Pérez, MP | 1 |
| Herrera, AJ; Osborne, NN | 1 |
| Holmberg, L; Seiger, A; Sundström, E; von Euler, M | 1 |
| Eybalin, M; Gervais d'Aldin, C; Puel, JL; Pujol, R | 1 |
| Hatanaka, K; Kawasaki-Yatsugi, S; Koshiya, K; Murase, K; Ohmori, J; Okada, M; Sakamoto, S; Shimizu-Sasamata, M; Togami, J; Usuda, S; Yatsugi, S | 1 |
| Hao, JX; Xu, XJ | 1 |
| Aeba, R; Ito, T; Kawada, S; Koto, A; Mitsumaru, A; Mori, A; Nakamichi, T; Odaguchi, H; Ueda, T; Yasudo, M; Yozu, R | 1 |
| Faussone-Pellegrini, MS; Lombardi, G; Matini, P; Moroni, F | 1 |
| Nakamichi, T | 1 |
| Coats, P; Hillier, C; Jarajapu, YP; MacDonald, A; McGrath, JC | 1 |
| Donello, JE; Gil, DW; Padillo, EU; Webster, ML; Wheeler, LA | 1 |
| Chahal, PS; Gee, BY; Hill, JM; Longhurst, JC; Tjen-A-Looi, SC | 1 |
| Aguilera, ME; Lafuente, MP; Mayor, S; Miralles de Imperial, J; Vidal-Sanz, M; Villegas-Pérez, MP | 1 |
| Nicklas, WJ; Zeevalk, GD | 1 |
| Eybalin, M; Puel, JL; Pujol, R | 1 |
2 trial(s) available for quinoxalines and Ischemia
| Article | Year |
|---|---|
Role of brimonidine in the treatment of clinically significant macular edema with ischemic changes in diabetic maculopathy.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Diabetic Retinopathy; Female; Humans; Ischemia; Macular Edema; Male; Middle Aged; Prospective Studies; Quinoxalines; Retinal Vessels; Visual Acuity | 2014 |
The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus.
Topics: Aneurysm; Antihypertensive Agents; Blood Glucose; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Ischemia; Middle Aged; Prospective Studies; Quinoxalines; Time Factors; Treatment Outcome; Vision, Ocular | 2004 |
24 other study(ies) available for quinoxalines and Ischemia
| Article | Year |
|---|---|
Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Topics: Analysis of Variance; Animals; Back; CD47 Antigen; Cyclic GMP; Enzyme Inhibitors; Gene Silencing; Ischemia; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Nitric Oxide; Nitrites; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Signal Transduction; Surgical Flaps; Thrombospondin 1; Xanthine Dehydrogenase | 2009 |
A glycine site-specific NMDA receptor antagonist protects retina ganglion cells from ischemic injury by modulating apoptotic cascades.
Topics: Animals; Apoptosis; Cytoprotection; Eye Proteins; Frozen Sections; Gene Expression Regulation; Glycine; In Situ Nick-End Labeling; Ischemia; Male; Microscopy, Confocal; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Retinal Ganglion Cells | 2010 |
Optogenetic analysis of neuronal excitability during global ischemia reveals selective deficits in sensory processing following reperfusion in mouse cortex.
Topics: Anesthetics, Local; Animals; Bacterial Proteins; Carrier Proteins; Channelrhodopsins; Disease Models, Animal; Electroencephalography; Evoked Potentials; Excitatory Amino Acid Antagonists; Forelimb; Hyperalgesia; In Vitro Techniques; Ischemia; Luminescent Proteins; Membrane Potentials; Mice; Mice, Transgenic; Neurons; Optogenetics; Physical Stimulation; Quinoxalines; Reperfusion Injury; Tetrodotoxin; Valine | 2012 |
Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; bcl-2-Associated X Protein; bcl-Associated Death Protein; Brimonidine Tartrate; DNA-Binding Proteins; Glutamic Acid; Ischemia; Mitochondrial Proteins; Oxidative Phosphorylation; Oxidative Stress; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Receptors, N-Methyl-D-Aspartate; Retina; Retinal Diseases; Retinal Ganglion Cells; Superoxide Dismutase; Transcription Factors | 2012 |
AMPA/kainate-type glutamate receptor antagonist reduces progressive inner hair cell loss after transient cochlear ischemia.
Topics: Acoustic Stimulation; Action Potentials; Animals; Cochlea; Cochlear Nerve; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Gerbillinae; Hair Cells, Auditory, Inner; Hearing; Immunohistochemistry; Ischemia; Male; Microscopy, Electron; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synapses | 2003 |
Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis.
Topics: Adenoviridae; Animals; Blotting, Western; Capillaries; Cell Adhesion; Cell Division; Cell Movement; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; DNA, Complementary; Dose-Response Relationship, Drug; Endothelium; Endothelium, Vascular; Enzyme Inhibitors; Gene Transfer Techniques; Humans; Ischemia; Laser-Doppler Flowmetry; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase; Nitroso Compounds; Oxadiazoles; Phosphatidylinositol 3-Kinases; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Recombinant Proteins; S-Nitrosoglutathione; Time Factors | 2003 |
Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury.
Topics: Administration, Inhalation; Animals; Blood Vessels; Carbon Monoxide; Carboxyhemoglobin; Corrosion Casting; Cytokines; Enzyme Inhibitors; Gases; Guanylate Cyclase; Inflammation Mediators; Intestine, Small; Ischemia; Male; Osmolar Concentration; Oxadiazoles; Plasminogen Activator Inhibitor 1; Platelet Endothelial Cell Adhesion Molecule-1; Quinoxalines; Rats; Rats, Inbred Lew; Regional Blood Flow; Reperfusion Injury; RNA, Messenger; Survival Analysis | 2003 |
Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine.
Topics: Afferent Pathways; Animals; Axonal Transport; Brain Stem; Brimonidine Tartrate; Cholera Toxin; Eye; Female; Functional Laterality; Image Processing, Computer-Assisted; Immunohistochemistry; Ischemia; Mesencephalon; Nerve Degeneration; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Staining and Labeling | 2003 |
Selective sparing of hippocampal CA3 cells following in vitro ischemia is due to selective inhibition by acidosis.
Topics: Acidosis; Animals; Animals, Newborn; Calcium; Cell Death; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Hydrogen-Ion Concentration; Ischemia; Mice; Neural Inhibition; Neurons; Organ Culture Techniques; Patch-Clamp Techniques; Quinoxalines; Time Factors; Valine | 2005 |
Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine.
Topics: Animals; Brimonidine Tartrate; Electroretinography; Female; Ischemia; Ligation; Nerve Degeneration; Neuroprotective Agents; Ophthalmic Artery; Quinoxalines; Rats; Rats, Sprague-Dawley; Retina; Retinal Degeneration; Retinal Ganglion Cells; Retinal Vessels; Superior Colliculi; Time Factors; Visual Pathways | 2005 |
The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Aminobutyrates; Animals; Cycloleucine; Dextromethorphan; Eye Proteins; gamma-Aminobutyric Acid; Glucose; Glutamates; Glutamic Acid; Intraocular Pressure; Ischemia; Kainic Acid; Kynurenic Acid; Memantine; N-Methylaspartate; Oxygen; Potassium Cyanide; Quinoxalines; Rabbits; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Retina; Retinal Vessels; Serotonin | 1994 |
NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
Topics: Analysis of Variance; Animals; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Ischemia; Lasers; Nerve Degeneration; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Reference Values; Spinal Cord; Time Factors | 1994 |
Pathophysiology of the glutamatergic synapses in the cochlea.
Topics: Animals; Cochlea; Dendrites; Dopamine; Glutamates; Glutamic Acid; Guinea Pigs; Hair Cells, Auditory, Inner; Ischemia; Piribedil; Quinoxalines; Receptors, Glutamate; Synapses; Vestibulocochlear Nerve | 1993 |
YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Topics: Animals; Anticonvulsants; Brain Ischemia; Cerebral Infarction; Corpus Striatum; Gerbillinae; Ischemia; Male; Mice; Mice, Inbred DBA; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Seizures | 1996 |
Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Topics: Animals; Behavior, Animal; Chronic Disease; Dextromethorphan; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Hyperalgesia; Ischemia; Motor Activity; Pipecolic Acids; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Regional Blood Flow; Spinal Cord; Spinal Cord Injuries | 1996 |
Detrimental effects of exogenous glutamate on spinal cord neurons during brief ischemia in vivo.
Topics: Animals; Excitatory Amino Acid Antagonists; Glutamic Acid; Ischemia; Neurons; Paraplegia; Paresis; Quinoxalines; Rabbits; Spinal Cord | 1997 |
Ultrastructural and biochemical studies on the neuroprotective effects of excitatory amino acid antagonists in the ischemic rat retina.
Topics: Animals; Choline O-Acetyltransferase; Excitatory Amino Acid Antagonists; Glutamate Decarboxylase; Ischemia; Kynurenic Acid; Light; Microscopy, Electron; Neuroprotective Agents; Quinoxalines; Radiation Injuries, Experimental; Rats; Retina; Retinal Vein Occlusion; Retinal Vessels; Rose Bengal | 1997 |
[Glutamate neurotoxicity during spinal cord ischemia--neuroprotective effects of glutamate receptor antagonists].
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutamates; Ischemia; Neuroprotective Agents; Quinoxalines; Rabbits; Spinal Cord | 1998 |
Increased alpha(1)- and alpha(2)-adrenoceptor-mediated contractile responses of human skeletal muscle resistance arteries in chronic limb ischemia.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Arteries; Brimonidine Tartrate; Chronic Disease; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Ischemia; Leg; Male; Middle Aged; Muscle, Skeletal; Norepinephrine; Quinoxalines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vasoconstriction; Vasoconstrictor Agents | 2001 |
alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aspartic Acid; Brimonidine Tartrate; Chromatography, Liquid; Electroretinography; Extracellular Space; Glutamic Acid; Ischemia; Male; Mass Spectrometry; Quinoxalines; Rats; Rats, Inbred BN; Retina; Retinal Ganglion Cells; Retinal Vessels; Vitreous Body; Yohimbine | 2001 |
Role of spinal NMDA and non-NMDA receptors in the pressor reflex response to abdominal ischemia.
Topics: 2-Amino-5-phosphonovalerate; Abdomen; Animals; Baroreflex; Cats; Decerebrate State; Excitatory Amino Acid Antagonists; Female; Ischemia; Male; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 2002 |
Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cell Death; Dose-Response Relationship, Drug; Ischemia; Microscopy, Fluorescence; Quinoxalines; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal Ganglion Cells; Time Factors | 2002 |
NMDA receptors, cellular edema, and metabolic stress.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Chickens; Dizocilpine Maleate; Edema; Electron Transport; Glycolysis; Hypoglycemia; Hypoxia; Iodoacetates; Iodoacetic Acid; Ischemia; N-Methylaspartate; Potassium Cyanide; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Retina; Tetrodotoxin | 1992 |
Implication of non-NMDA and NMDA receptors in cochlear ischemia.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cochlea; Dendrites; Guinea Pigs; Hair Cells, Auditory; Ischemia; Microscopy, Electron; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Reperfusion | 1992 |